TOI
The Oncology Institute, Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $0.49 | $4.00 | +725% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $0.45 | $4.00 | +789% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | $4.00 | — |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $0.45 | $4.00 | +789% |
| AQR Capital Management | Q4 2025(8Q snapshot) | 2Q | $3.97 | $4.00 | +1% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Point72 Asset Management | Q1 2026 | Q2 2026 | → $3.98 | +50% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Oncology Institute, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.
- Form 40001079973-26-000801Jun 9, 2026
- Form 40000921895-26-001564Jun 5, 2026
- Form 40001079973-26-000727May 22, 2026
- Form 40001079973-26-000725May 22, 2026
- Form 40001079973-26-000723May 22, 2026
- Form 40000921895-26-001466May 21, 2026
- Form 40000921895-26-001444May 20, 2026
- Form 40001079973-26-000527Apr 23, 2026
- Form 40001079973-26-000525Apr 23, 2026
- Form 40001079973-26-000499Apr 16, 2026
- Form 40000921895-26-000958Apr 13, 2026
- Form 40001079973-26-000449Apr 1, 2026
- Form 40001079973-26-000447Apr 1, 2026
- Form 40001079973-26-000443Apr 1, 2026
- Form 40001079973-26-000440Apr 1, 2026
Fundamentals
XBRL · The Oncology Institute, Inc.Annual figures sourced directly from The Oncology Institute, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Oncology Institute, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 22, 2026
- 8-KFORM 8-KMay 7, 2026
- 10-QQuarterly reportMay 7, 2026
- DEF 14AProxy statementApr 30, 2026
- 8-KFORM 8-KMar 13, 2026
- 10-KAnnual reportMar 12, 2026
- 8-KFORM 8-KMar 12, 2026
- 8-KFORM 8-KFeb 23, 2026
- 8-KFORM 8-KJan 12, 2026
- 8-KFORM 8-KJan 7, 2026
- 8-KFORM 8-KDec 1, 2025
- 8-KFORM 8-KNov 14, 2025
- 10-QQuarterly reportNov 13, 2025
- 8-KFORM 8-KNov 13, 2025
- 8-KFORM 8-KNov 6, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $3.98 | $4.00 | +1% |
| Point72 Asset Management | Q1 2026 | Q2 2026 | $2.66 | $3.98 | +50% |
| Citadel Advisors | Q4 2025 | Q1 2026 | $3.97 | $2.66 | -33% |
| AQR Capital Management | Q4 2025 | open | $3.97 | $4.00 | +1% |
| Two Sigma Investments | Q3 2025 | open | $3.67 | $4.00 | +9% |
| Millennium Management | Q3 2025 | open | $3.67 | $4.00 | +9% |
| Citadel Advisors | Q3 2024 | Q1 2025 | $0.45 | $0.96 | +114% |
| Citadel Advisors | Q3 2024 | Q2 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | Q4 2024 | $0.45 | $0.23 | -48% |
| Renaissance Technologies | Q3 2024 | open | $0.49 | $4.00 | +725% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.